Carl Ascoli, Ph.D. is the Chief Science Officer of Rockland Immunochemicals and has more than 30 years of academic and industrial experience and a broad knowledge in virology, immunology, host-agent interaction, autoimmune diseases, cancer biology, antibody production and engineering, protein purification and DNA recombinant technology.
Dr. Ascoli joined Rockland Immunochemicals in 1991 and began to apply his skills in molecular immunology to solve problems for academic collaborators who required the production of highly specific polyclonal and monoclonal antibodies for research. For more than 20 years Dr. Ascoli has established collaborations with principal investigators at academic and research throughout North America, Europe and Japan.
read more